Charles Schwab’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Charles Schwab’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,822	Closed	-$46.6K	–	3559
2023 Q4	$46.6K	Hold	38,822	–	–	﹤0.01%	3412
2023 Q3	$33.5K	Sell	38,822 -6,860	-15%	-$7.51K	﹤0.01%	3451
2023 Q2	$54.8K	Buy	+45,682	New	+$229K	﹤0.01%	3412
2022 Q2	–	Sell	-34,429	Closed	-$175K	–	3679
2022 Q1	$175K	Sell	34,429 -3,166	-8%	-$25.4K	﹤0.01%	3329
2021 Q4	$485K	Buy	37,595 +18,698	+99%	+$267K	﹤0.01%	3152
2021 Q3	$283K	Hold	18,897	–	–	﹤0.01%	3279
2021 Q2	$294K	Buy	+18,897	New	+$331K	﹤0.01%	3245

Charles Schwab's RAIN Position: Q1 2024 in Review

Charles Schwab sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 38,822 shares — an estimated $46.6K sold.

Charles Schwab first reported a position in RAIN in Q2 2021 and held it in 7 quarters. The position peaked at $485K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Charles Schwab reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Charles Schwab sold 38,822 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $46.6K.
Charles Schwab first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Charles Schwab's Rain Oncology Inc. Common Stock position peaked at $485K in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.